Results 241 to 250 of about 238,748 (288)

Graham-Little-Piccardi-Lassueur Syndrome: Favorable Response to Isotretinoin Treatment. [PDF]

open access: yesDermatol Pract Concept
Guerrero-Cornejo S   +2 more
europepmc   +1 more source

Integrating polygenic and methylation risk scores for pleural mesothelioma risk stratification

open access: yesInternational Journal of Cancer, Volume 158, Issue 11, Page 2866-2879, 1 June 2026.
What's new? Asbestos exposure is a major risk factor for pleural mesothelioma (PM). Most asbestos‐exposed individuals do not develop PM, suggesting that it arises from a complex interplay between environmental and genetic factors. This study examined the utility of polygenic risk scores (PRS) and methylation risk scores (MRS) in incorporating genetic ...
Khadija Sana Hafeez   +26 more
wiley   +1 more source

Correction: Evidence and reality: an observational study on pharmacological outcomes in advanced head and neck tumors. [PDF]

open access: yesFront Oncol
Jordán de Luna C   +6 more
europepmc   +1 more source

Educational Choices and Social Inequalities: How Research Addresses Students' Decision‐Making

open access: yesEuropean Journal of Education, Volume 61, Issue 2, June 2026.
ABSTRACT Educational choices are a key area of research within the sociology of education, yet the concept of choice remains contested. This paper examines how European research analyses students' decision‐making at key educational transitions and their relationship to social positions.
Sara Gil   +3 more
wiley   +1 more source

Innovation Ecosystems in Catalonia: Exploring Location Patterns of High‐Tech Firms

open access: yesGrowth and Change, Volume 57, Issue 2, June 2026.
ABSTRACT This paper analyses high‐tech firms' location determinants in Catalonia, Spain, using 2010–2019 firm data, and spatial models to assess spillover and industry‐specific factor effects. Results show that high‐tech firms, especially in services, are clustered in busy, wealthy cities with strong innovation hubs, while non‐high‐tech firms prefer ...
Keli Araujo‐Rocha   +1 more
wiley   +1 more source

Post‐surgery level of circulating DNA in stage III colon cancer patients: Impact on the reliability of minimal residual disease detection

open access: yesInternational Journal of Cancer, Volume 158, Issue 10, Page 2771-2783, 15 May 2026.
What's New? Circulating nuclear DNA (cir‐nDNA)‐based assessment of minimal residual disease (MRD) offers powerful post‐surgery prognostic insight for stage III colon cancer (CC). Sparse knowledge of post‐surgical variations and origins in cir‐nDNA, however, has limited its clinical application.
Andrei Kudriavtsev   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy